about us

about us

Our mission is to become the leader in developing stem cell therapies, acquiring requisite patents, manufacturing and commercializing pioneering methods of osseointegration for endentulous patients that have compromised immunity. Through our research into the use of mesenchymal stem cells and PRP ( plasma rich platelets)  for tissue replacement therapies, Bay Street Stem Cell Science aims to continuously improve all facets of soft tissue and bone regeneration in a patient care continuum that is changing constantly and faced with increasing challenges.

victor terranova dmd bay street stem cell science

victor terranova, d.m.d, m.s, Ph.D. - CHIEF executive officer

Dr. Victor Terranova received his BA from Rutgers College of Rutgers University in New Jersey. He received his DMD from the University of Medicine and Dentistry of New Jersey in 1972 and his MS and PhD in Molecular Biology at the University of Rochester in 1978. Specialty training in Periodontolgy was completed at the Eastman Dental Center of Strong Memorial Hospital, affiliated with the University of Rochester under the mentor of Dr. Helmut A. Zander in 1976.


After his training Dr. Terranova spent seven years as Senior Staff at the National Institutes of Health and National Institute of Dental Research.

His academic appointments include professorships at Loyola University, University of the State of New York at Buffalo, Roswell Park Memorial Institute and Columbia University in New York City.

Dr. Terranova is currently on the faculty of the California Implant institute.
His academic appointments include professorships at Loyola University, University of the State of New York at Buffalo, Roswell Park Memorial Institute and Columbia University in New York City.

Dr. Terranova is currently on the faculty of the California Implant institute.

Dr. Terranova has a wide spectrum of clinical talents. In addition to being a board eligible periodontist capable of performing a full range of periodontal diagnosis and treatment, Dr. Terranova is also extremly skilled in implant surgery and many phases of oral and maxilla - facial surgery. In 30 years of practice, Dr. Terranova has performed thousands of surgical procedures, including implant placement, periodontal surgery and grafts, sinus augmentation, and simple and complicated tooth extractions including 3rd molar extractions.

In addition to 30 years of clinical experience Dr. Terranova has published over 150 articles in molecular biology of cancer and clinical dentistry.

After his training Dr. Terranova spent seven years as Senior Staff at the National Institutes of Health and National Institute of Dental Research.

Victor Terranova, DMD, MS, PhD is the CEO and President of Bay Street Stem Cell Science. 

David Scott Salomon, Ph.D. - Chief scientific officer

After obtaining my Ph.D. from the State University of New York at Albany, I assumed a postdoctoral fellow position at the Roche Institute of Molecular Biology in Nutley, NJ, and spent six years as a staff fellow in the Laboratory of Developmental Biology in the National Institute of Dental Research. I have been a breast cancer researcher at the National Cancer Institute in Bethesda, MD and Frederick, MD for over thirty-seven years.

I am currently the Chief of The Tumor Growth Factor Section in the Mouse Cancer Genetics Program at the Frederick National Laboratory for Cancer Research. I have 250 publications in peer-reviewed journals, 8 patents and serve on the editorial board of several journals. My research is devoted to understanding the role of embryonic genes and signaling pathways controlled by these genes in rodent and human mammary stem cells and in the maintenance and self-renewal of breast cancer stem cells. Of particular interest is the function of Cripto-1/TDGF-1 in regulating stem cell functions. In vitro cell models and in vivo mouse transgenic and knockout models are being employed to delineate the mechanism(s) by which Cripto-1 might regulate stem cell identity and cancer progression in the mammary gland. We have already identified Cripto-1 as a diagnostic and therapeutic target in breast, colon and lung cancer and are advancing this research on several fronts. On the diagnostic front, this STTR leverages our prior findingwe have found that Cripto-1’s is significantly upregulated in breast cancer versus controls to create an easy and efficatious alternitive for the 21 million women who choose not to get mammograms.

On the therapeutic front, we are attempting to screen for other drugs or small molecules that might attenuate other stem cell-related signaling pathways such as Wnt and Notch and that might potentially synergize with anti-Cripto-1 agents in eradicating tumor cell growth, progression and cancer stem cell populations. It’s my personal hope that these efforts and my thirty-seven years of breast cancer research cullimanteculminate in commercial products that impact clinical practice and reduce mortality.

1969 B.A. (Biology) Clark University, Worcester, MA
1973 Ph.D. (Biochemistry/Cell Biology) State University of New York, Albany, NY

COMPLETED RESEARCH

Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. (2013) 
To investigate the transcriptional regulation of CR-1 gene expression and its critical role in the pathogenesis of human cancer.I served as senior investigator.

Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. (2013)
To demonstrate that the mammary microenvironment is sufficient to suppress ES cell induced     tumorigenesis and to provide signals necessary to induce differentiation of ES cells to a mammary cell fate.I serve as a co-senior investigator.

Identification of caveolin-1 as a potential causative factor in the generation of Trastuzmab resistance in breast cancer cells. (2013)
To identify possible causative factors to Trastuzmab resistance in breast cancer patients.I served as senior investigator.

STEVEN R. CISTERNAS, DDS - CHIEF RESEARCH OFFICER

BIO WILL GO HERE AND WE NEED A CLEARER PIC...WE WILL TAKE ONE WHEN WE ARE OUT THERE.

Ri

Th

THE OTHER GUY GOES HERE

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old.

Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there isn't anything embarrassing hidden in the middle of text.

Select Color